Changes between Initial Version and Version 1 of Research/DesignStudy/Meetings/2019/12-03


Ignore:
Timestamp:
Dec 2, 2019, 10:13:39 PM (5 years ago)
Author:
kurup
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • Research/DesignStudy/Meetings/2019/12-03

    v1 v1  
     1= LhARA pre-CDR Meeting 3rd Dec 2019 =
     2
     3== Meeting details ==
     4
     514:00 Room 532, Blackett Lab.
     6
     7Zoom details:
     8
     9 Join Zoom Meeting https://ukri.zoom.us/j/865262978
     10
     11 Phone one-tap:
     12 United Kingdom: +442034815237!,,865262978# or +442039663809!,,865262978#
     13
     14 Join by Telephone For higher quality, dial a number based on your current location.
     15    United Kingdom:
     16      +44 203 481 5237\\
     17      +44 203 966 3809\\
     18      +44 131 460 1196\\
     19      +44 203 051 2874
     20 Meeting ID: 865 262 978
     21
     22 Join from an H.323/SIP room system H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan)
     23 Meeting ID: 865 262 978
     24
     25
     26 International numbers https://ukri.zoom.us/u/ap9aBI2Eh
     27
     28 SIP: 865262978@zoomcrc.com \\
     29 Skype for Business (Lync) https://ukri.zoom.us/skype/865262978 \\
     30 Skype on a SurfaceHub SIP: 865262978@lync.zoom.us https://ukri.zoom.us/skype/865262978
     31
     32
     33== Agenda ==
     34 * Action items from last meeting.
     35   * AK to note the instrumentation requirements for the definition of the baseline.
     36   * OE to circulate what was done for safety case for the laser in 027.
     37   * AK to arrange meeting between laser and capture WPMs.
     38   * JPar to define beam specs for in vivo experiments.
     39   * AK to prepare list of the 4 abstracts needed. One abstract, 4 different "spins".
     40   * AK to draft outline R&D plan and circulate for comments before Thursday.
     41
     42
     43 * System updates.
     44  * Laser driven proton and ion source.
     45  * Proton and ion capture.
     46  * Stage 1 beam transport: Beam transport and delivery to the in vitro end station.
     47  * Stage 2 beam transport: Post-acceleration and beam delivery to the in vivo end station.
     48  * Biological end stations.
     49  * Infrastructure and Integration.
     50  * Project plan for the delivery of LhARA.
     51  * Safety.
     52  * End-to-end simulation.
     53  * Instrumentation.
     54 * A.O.B.
     55  * Plenary meeting talks.
     56  * Next meeting.
     57
     58== Notes ==
     59Present:
     60
     61Apologies:
     62
     63== Action Items ==